Cargando…

CE‐MS for metabolomics: Developments and applications in the period 2016–2018

In the field of metabolomics, CE‐MS is now recognized as a strong analytical technique for the analysis of (highly) polar and charged metabolites in a wide range of biological samples. Over the past few years, significant attention has been paid to the design and improvement of CE‐MS approaches for...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramautar, Rawi, Somsen, Govert W., de Jong, Gerhardus J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6586046/
https://www.ncbi.nlm.nih.gov/pubmed/30232802
http://dx.doi.org/10.1002/elps.201800323
_version_ 1783428827390672896
author Ramautar, Rawi
Somsen, Govert W.
de Jong, Gerhardus J.
author_facet Ramautar, Rawi
Somsen, Govert W.
de Jong, Gerhardus J.
author_sort Ramautar, Rawi
collection PubMed
description In the field of metabolomics, CE‐MS is now recognized as a strong analytical technique for the analysis of (highly) polar and charged metabolites in a wide range of biological samples. Over the past few years, significant attention has been paid to the design and improvement of CE‐MS approaches for (large‐scale) metabolic profiling studies and for establishing protocols in order to further expand the role of CE‐MS in metabolomics. In this paper, which is a follow‐up of a previous review paper covering the years 2014–2016 (Electrophoresis 2017, 38, 190–202), main advances in CE‐MS approaches for metabolomics studies are outlined covering the literature from July 2016 to June 2018. Aspects like developments in interfacing designs and data analysis tools for improving the performance of CE‐MS for metabolomics are discussed. Representative examples highlight the utility of CE‐MS in the fields of biomedical, clinical, microbial, and plant metabolomics. A complete overview of recent CE‐MS‐based metabolomics studies is given in a table, which provides information on sample type and pretreatment, capillary coatings and MS detection mode. Finally, some general conclusions and perspectives are given.
format Online
Article
Text
id pubmed-6586046
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-65860462019-06-27 CE‐MS for metabolomics: Developments and applications in the period 2016–2018 Ramautar, Rawi Somsen, Govert W. de Jong, Gerhardus J. Electrophoresis Part III. Applications: Biomarkers, Proteomics, Metabolomics, Biomedical and Lipids In the field of metabolomics, CE‐MS is now recognized as a strong analytical technique for the analysis of (highly) polar and charged metabolites in a wide range of biological samples. Over the past few years, significant attention has been paid to the design and improvement of CE‐MS approaches for (large‐scale) metabolic profiling studies and for establishing protocols in order to further expand the role of CE‐MS in metabolomics. In this paper, which is a follow‐up of a previous review paper covering the years 2014–2016 (Electrophoresis 2017, 38, 190–202), main advances in CE‐MS approaches for metabolomics studies are outlined covering the literature from July 2016 to June 2018. Aspects like developments in interfacing designs and data analysis tools for improving the performance of CE‐MS for metabolomics are discussed. Representative examples highlight the utility of CE‐MS in the fields of biomedical, clinical, microbial, and plant metabolomics. A complete overview of recent CE‐MS‐based metabolomics studies is given in a table, which provides information on sample type and pretreatment, capillary coatings and MS detection mode. Finally, some general conclusions and perspectives are given. John Wiley and Sons Inc. 2018-10-01 2019-01 /pmc/articles/PMC6586046/ /pubmed/30232802 http://dx.doi.org/10.1002/elps.201800323 Text en © 2018 The Authors. Electrophoresis Published by WILEY‐VCH Verlag GmbH & Co. KGaA, Weinheim. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Part III. Applications: Biomarkers, Proteomics, Metabolomics, Biomedical and Lipids
Ramautar, Rawi
Somsen, Govert W.
de Jong, Gerhardus J.
CE‐MS for metabolomics: Developments and applications in the period 2016–2018
title CE‐MS for metabolomics: Developments and applications in the period 2016–2018
title_full CE‐MS for metabolomics: Developments and applications in the period 2016–2018
title_fullStr CE‐MS for metabolomics: Developments and applications in the period 2016–2018
title_full_unstemmed CE‐MS for metabolomics: Developments and applications in the period 2016–2018
title_short CE‐MS for metabolomics: Developments and applications in the period 2016–2018
title_sort ce‐ms for metabolomics: developments and applications in the period 2016–2018
topic Part III. Applications: Biomarkers, Proteomics, Metabolomics, Biomedical and Lipids
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6586046/
https://www.ncbi.nlm.nih.gov/pubmed/30232802
http://dx.doi.org/10.1002/elps.201800323
work_keys_str_mv AT ramautarrawi cemsformetabolomicsdevelopmentsandapplicationsintheperiod20162018
AT somsengovertw cemsformetabolomicsdevelopmentsandapplicationsintheperiod20162018
AT dejonggerhardusj cemsformetabolomicsdevelopmentsandapplicationsintheperiod20162018